Original from: mddionline
Author: Daphne Allen
Image Credit: JHVEPhoto – Adobe Stock
“Our efforts push on two prongs—innovation and safety, which we believe are two sides of the same coin,” Shuren shared as he kicked off the session. He added that such work includes “derisking the entire product lifecycle such that the development of and investment in medical devices and the U.S. marketplace is far more attractive.”
Understandably, COVID-19 still is “the top effort underway at the center,” he said, adding that they’ve seen a "massive increase in submissions and a big increase in workload." For instance, in 2020, the center saw a 38% increase in submissions, and it has brought almost 1700 medical devices to authorization in the United States, he said. “Critical to that was the regulatory flexibility of EUAs and extensive engagement with developers,” he added.
Click the following link to read the slideshow for updates on key CDRH projects. And be sure to click through to the end for a flashback to last year's CDRH Townhall.
https://www.mddionline.com/regulations/11-fda-plans-you-need-know-about/gallery?slide=1
China Association of In-vitro Diagnostics
Part of the information in our website is from the internet.
If by any chance it violates your rights, please contact us.